Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment

DISEASE CHARACTERISTICS: Diagnosis of neuroblastoma, as defined by 1 of the following: Histologically confirmed disease Bone marrow metastases plus high urine catecholamines High-risk disease meeting 1 of the following stage criteria: Stage IV, with 1 of the following: Any age with MYCN amplification > 18 months of age without MYCN amplification Stage III, with both of the following: Any age with MYCN amplification Unresectable disease Stage 4S with MYCN amplification Measurable or evaluable soft tissue disease Relapsed disease resistant to standard induction chemotherapy and salvage therapy PATIENT CHARACTERISTICS: Age Any age Performance status Not specified Life expectancy Not specified Hematopoietic Not specified Hepatic No severe hepatic toxicity ≥ grade 3 Renal No severe renal toxicity ≥ grade 3 Cardiovascular No severe cardiac toxicity ≥ grade 3 Pulmonary No severe pulmonary toxicity ≥ grade 3 Other Not pregnant Negative pregnancy test No severe neurologic toxicity ≥ grade 3 No severe gastrointestinal toxicity ≥ grade 3 No other severe major organ dysfunction except ototoxicity No history of allergy to mouse proteins No active life-threatening infection No human anti-mouse antibody titer > 1,000 ELISA units/mL PRIOR CONCURRENT THERAPY: Biologic therapy Not specified Chemotherapy See Disease Characteristics Endocrine therapy Not specified Radiotherapy Not specified Surgery Not specified